Makale detayı · 2020 · article
Local and Global Motions Underlying Antibiotic Binding in Bacterial Ribosome
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıJournal of Chemical Information and Modeling
- Katalog eşleşmesi (ISSN)Journal of Chemical Information and Modeling
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
- Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)
Özet
Abstract The bacterial ribosome is one of the most important targets in the treatment of infectious diseases. As antibiotic resistance in bacteria poses a growing threat, a significant amount of effort is concentrated on exploring new drug-binding sites where testable predictions are of significance. Here, we study the dynamics of a ribosomal complex and 67 small and large subunits of the ribosomal crystal structures (64 antibiotic-bound, 3 antibiotic-free) from Deinococcus radiodurans, Escherichia coli, Haloarcula marismortui, and Thermus thermophilus by the Gaussian network model. Interestingly, a network of nucleotides coupled in high-frequency fluctuations reveals known antibiotic-binding sites. These sites are seen to locate at the interface of dynamic domains that have an intrinsic dynamic capacity to interfere with functional globular motions. The nucleotides and the residues fluctuating in the fast and slow modes of motion thus have promise for plausible antibiotic-binding and allosteric sites that can alter antibiotic binding and resistance. Overall, the present analysis brings a new dynamic perspective to the long-discussed link between small-molecule binding and large conformational changes of the supramolecule.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
11atıfOpenAlex · cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 13 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- 2021 Repurposing of FDA‐approved drugs against active site and potential allosteric drug‐binding sites of COVID‐19 main proteaseAtıf 48 · OpenAlex
- 2021 Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main proteaseAtıf 48 · OpenAlex
- 2021 Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main proteaseAtıf 48 · OpenAlex
- 2023 Exploring species-specific inhibitors with multiple target sites on S. aureus pyruvate kinase using a computational workflowAtıf 8 · OpenAlex
- 2023 Exploring species-specific inhibitors with multiple target sites on S. aureus pyruvate kinase using a computational workflowAtıf 8 · OpenAlex
- 2024 Exploring Druggable Binding Sites on the Class A GPCRs Using the Residue Interaction Network and Site Identification by Ligand Competitive SaturationAtıf 6 · OpenAlex
- 2024 Identifying and Assessing Putative Allosteric Sites and Modulators for CXCR4 Predicted through Network Modeling and Site Identification by Ligand Competitive SaturationAtıf 6 · OpenAlex
- 2024 Exploring Druggable Binding Sites on the Class A GPCRs Using the Residue Interaction Network and Site Identification by Ligand Competitive SaturationAtıf 6 · OpenAlex
- 2024 Exploring Druggable Binding Sites on the Class A GPCRs Using the Residue Interaction Network and Site Identification by Ligand Competitive SaturationAtıf 6 · OpenAlex
- 2024 Identifying and Assessing Putative Allosteric Sites and Modulators for CXCR4 Predicted through Network Modeling and Site Identification by Ligand Competitive SaturationAtıf 6 · OpenAlex